Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Justus B Cohen

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
Journal of Virology|June 29, 2018
Cellular Antisilencing Elements Support Transgene Expression from Herpes Simplex Virus Vectors in the Absence of Immediate Early Gene ExpressionFang Han, Yoshitaka Miyagawa, Gianluca Verlengia, et al.
Cancer Gene Therapy|February 5, 2005
Combination gene therapy for glioblastoma involving herpes simplex virus vector-mediated codelivery of mutant IkappaBalpha and HSV thymidine kinaseShusuke Moriuchi, Joseph C Glorioso, Motohiko Maruno, et al.
The Journal of Gene Medicine|March 9, 2005
Enhanced efficacy of conditionally replicating herpes simplex virus (G207) combined with 5-fluorouracil and surgical resection in peritoneal cancer dissemination modelsKenji Nakano, Tomoki Todo, Gang Zhao, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 7, 2010
Bispecific adapter-mediated retargeting of a receptor-restricted HSV-1 vector to CEA-bearing tumor cellsHyunjung Baek, Hiroaki Uchida, Kyungok Jun, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 18, 2005
Herpes simplex virus targeting to the EGF receptor by a gD-specific soluble bridging moleculeKenji Nakano, Ryutaro Asano, Kouhei Tsumoto, et al.
Journal of Virology|February 15, 2005
Equine herpesvirus 1 utilizes a novel herpesvirus entry receptorArthur R Frampton, William F Goins, Justus B Cohen, et al.
Journal of Virology|December 15, 2005
Soluble V domain of Nectin-1/HveC enables entry of herpes simplex virus type 1 (HSV-1) into HSV-resistant cells by binding to viral glycoprotein DHeechung Kwon, Qing Bai, Hyun-Jung Baek, et al.
Journal of Virology|January 9, 2009
Generation of herpesvirus entry mediator (HVEM)-restricted herpes simplex virus type 1 mutant viruses: resistance of HVEM-expressing cells and identification of mutations that rescue nectin-1 recognitionHiroaki Uchida, Waris A Shah, Ali Ozuer, et al.
Veterinary Microbiology|August 29, 2009
Equine herpesvirus type 1 (EHV-1) utilizes microtubules, dynein, and ROCK1 to productively infect cellsArthur R Frampton, Hiroaki Uchida, Jens von Einem, et al.
Virology|March 9, 2011
Mechanism of HSV infection through soluble adapter-mediated virus bridging to the EGF receptorKenji Nakano, Masatoshi Kobayashi, Kei-ichiro Nakamura, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Journal of Virology|June 29, 2018
Cellular Antisilencing Elements Support Transgene Expression from Herpes Simplex Virus Vectors in the Absence of Immediate Early Gene ExpressionFang Han, Yoshitaka Miyagawa, Gianluca Verlengia, et al.
Cancer Gene Therapy|February 5, 2005
Combination gene therapy for glioblastoma involving herpes simplex virus vector-mediated codelivery of mutant IkappaBalpha and HSV thymidine kinaseShusuke Moriuchi, Joseph C Glorioso, Motohiko Maruno, et al.
The Journal of Gene Medicine|March 9, 2005
Enhanced efficacy of conditionally replicating herpes simplex virus (G207) combined with 5-fluorouracil and surgical resection in peritoneal cancer dissemination modelsKenji Nakano, Tomoki Todo, Gang Zhao, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 7, 2010
Bispecific adapter-mediated retargeting of a receptor-restricted HSV-1 vector to CEA-bearing tumor cellsHyunjung Baek, Hiroaki Uchida, Kyungok Jun, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 18, 2005
Herpes simplex virus targeting to the EGF receptor by a gD-specific soluble bridging moleculeKenji Nakano, Ryutaro Asano, Kouhei Tsumoto, et al.
Journal of Virology|February 15, 2005
Equine herpesvirus 1 utilizes a novel herpesvirus entry receptorArthur R Frampton, William F Goins, Justus B Cohen, et al.
Journal of Virology|December 15, 2005
Soluble V domain of Nectin-1/HveC enables entry of herpes simplex virus type 1 (HSV-1) into HSV-resistant cells by binding to viral glycoprotein DHeechung Kwon, Qing Bai, Hyun-Jung Baek, et al.
Journal of Virology|January 9, 2009
Generation of herpesvirus entry mediator (HVEM)-restricted herpes simplex virus type 1 mutant viruses: resistance of HVEM-expressing cells and identification of mutations that rescue nectin-1 recognitionHiroaki Uchida, Waris A Shah, Ali Ozuer, et al.
Veterinary Microbiology|August 29, 2009
Equine herpesvirus type 1 (EHV-1) utilizes microtubules, dynein, and ROCK1 to productively infect cellsArthur R Frampton, Hiroaki Uchida, Jens von Einem, et al.
Virology|March 9, 2011
Mechanism of HSV infection through soluble adapter-mediated virus bridging to the EGF receptorKenji Nakano, Masatoshi Kobayashi, Kei-ichiro Nakamura, et al.
Pageof 5